Drugs for the treatment of hypercalcaemia
Open Access
- 1 March 1974
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 50 (581) , 158-162
- https://doi.org/10.1136/pgmj.50.581.158
Abstract
Summary: Hypercalcaemia is ordinarily treated by treatment of the underlying disorder. In some cases, as in malignant disease, in vitamin D poisoning and after a failed parathyroidectomy, the hypercalcaemia itself needs to be treated. A large number of methods have been advocated for this, but phosphate is the drug of choice in most patients. This paper outlines its use, mode of action and side effects and reviews the other methods proposed for the management of hypercalcaemia.Keywords
This publication has 36 references indexed in Scilit:
- Stilboestrol diphosphate in hypercalcaemia due to parathyroid carcinoma.BMJ, 1973
- Vitamin D Intoxication Treated with Porcine CalcitoninBMJ, 1972
- THE EFFECT OF OESTROGENS ON THE RESPONSE OF BONE TO PARATHYROID HORMONE IN VITROJournal of Endocrinology, 1972
- Diagnosis and treatment of hypercalcaemia.BMJ, 1972
- Long-term administration of calcitonin for hypercalcemia secondary to recurrent parathyroid carcinomaCancer, 1972
- Effect of Frusemide Administration on Calcium ExcretionBMJ, 1971
- FAILURE OF CORTICOSTEROID THERAPY TO CORRECT THE HYPERCALCÆMIA OF MALIGNANT DISEASEThe Lancet, 1970
- Renal Effects of CalcitoninBMJ, 1970
- Phosphate Treatment of Hypercalcaemia Due to CarcinomaBMJ, 1968
- Some Problems of HyperparathyroidismBMJ, 1962